The protective effect of dexmedetomidine on bupivacaineinduced sciatic nerve inflammation is mediated by mast cells

Clinical and Investigative Medicine

Volumn 36, Issue 2, 2013, Pages

  Tüfek, Adnan ^a   Kaya, Savaş ^a   Tokgöz, Orhan ^a   Firat, Uǧur ^a   Evliyaoǧlu, Osman ^a   Çelik, Feyzi ^a   Karaman, Haktan ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE; BUPIVACAINE; DEXMEDETOMIDINE; GALECTIN 3; GELATINASE A; GELATINASE B; LOCAL ANESTHETIC AGENT; MMP2 PROTEIN, RAT; MMP9 PROTEIN, RAT; PON 1 PROTEIN, RAT;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; EDEMA; FEMALE; INFLAMMATION; MAST CELL; METABOLISM; METHODOLOGY; NERVE BLOCK; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RAT; SCIATIC NERVE; WISTAR RAT;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANESTHETICS, LOCAL; ANIMALS; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; BUPIVACAINE; DEXMEDETOMIDINE; EDEMA; FEMALE; GALECTIN 3; INFLAMMATION; MAST CELLS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NERVE BLOCK; OXIDATIVE STRESS; RATS; RATS, WISTAR; SCIATIC NERVE;

EID: 84877045206     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Casati A, Putzu M. Bupivacaine, levobupivacaine and ropivacaine: are they clinically different?. Best Pract Res Clin Anaesthesiol. 2005 Jun;19(2):247-68. PubMed PMID: 15966496. Epub 2005/06/22. eng.
2. Perez-Castro R, Patel S, Garavito-Aguilar ZV, Rosenberg A, Recio-Pinto E, Zhang J, et al. Cytotoxicity of local anesthetics in human neuronal cells. Anesth Analg. 2009 Mar;108(3):997-1007. PubMed PMID: 19224816. Epub 2009/02/20. eng.
3. Selander D, Brattsand R, Lundborg G, Nordborg C, Olsson Y. Local anesthetics: importance of mode of application, concentration and adrenaline for the appearance of nerve lesions. An experimental study of axonal degeneration and barrier damage after intrafascicular injection or topical application of bupivacaine (Marcain). Acta anaesthesiologica Scandinavica. 1979 Apr;23(2):127-36. PubMed PMID: 442943.
4. Park CJ, Park SA, Yoon TG, Lee SJ, Yum KW, Kim HJ. Bupivacaine induces apoptosis via ROS in the Schwann cell line. J Dent Res. 2005 Sep;84(9):852-7. PubMed PMID: 16109997. Epub 2005/08/20. eng.
5. Cote CH, Tremblay MH, Duchesne E, Lapoite BM. Inflammation-induced leukocyte accumulation in injured skeletal muscle: role of mast cells. Muscle Nerve. 2008 Jun;37(6):754-63. PubMed PMID: 18506708. Epub 2008/05/29. eng.
6. Novak R, Dabelic S, Dumic J. Galectin-1 and galectin-3 expression profiles in classically and alternatively activated human macrophages. Biochim Biophys Acta. 2011 Dec 6. PubMed PMID: 22155450. Epub 2011/12/14. Eng.
7. Reichert F, Saada A, Rotshenker S. Peripheral nerve injury induces Schwann cells to express two macrophage phenotypes: phagocytosis and the galactose-specific lectin MAC-2. J Neurosci. 1994 May;14(5 Pt 2):3231-45. PubMed PMID: 8182468. Epub 1994/05/01. eng.
8. Matsumoto Y, Park IK, Kohyama K. Matrix metalloproteinase (MMP)-9, but not MMP-2, is involved in the development and progression of C protein-induced myocarditis and subsequent dilated cardiomyopathy. J Immunol. 2009 Oct 1;183(7):4773-81. PubMed PMID: 19734212. Epub 2009/09/08. eng.
9. Rodriguez D, Morrison CJ, Overall CM. Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics. Biochim Biophys Acta. 2010 Jan;1803(1):39-54. PubMed PMID: 19800373. Epub 2009/10/06. eng.
10. Bergman MR, Teerlink JR, Mahimkar R, Li L, Zhu BQ, Nguyen A, et al. Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction. Am J Physiol Heart Circ Physiol. 2007 Apr;292(4):H1847-60. PubMed PMID: 17158653. Epub 2006/12/13. eng.
11. Kennelly R, Conneely JB, Bouchier-Hayes D, Winter DC. Mast cells in tissue healing: from skin to the gastrointestinal tract. Curr Pharm Des. 2011 Nov;17(34):3772-5. PubMed PMID: 22103847. Epub 2011/11/23. eng.
12. Younan GJ, Heit YI, Dastouri P, Kekhia H, Xing W, Gurish MF, et al. Mast cells are required in the proliferation and remodeling phases of microdeformational wound therapy. Plast Reconstr Surg. 2011 Dec;128(6):649e-58e. PubMed PMID: 22094766. Epub 2011/11/19. eng.
13. Theoharides TC, Alysandratos KD, Angelidou A, Delivanis DA, Sismanopoulos N, Zhang B, et al. Mast cells and inflammation. Biochim Biophys Acta. 2012 Jan;1822(1):21-33. PubMed PMID: 21185371. Pubmed Central PMCID: 3318920. Epub 2010/12/28. eng.
14. Enoksson M, Lyberg K, Moller-Westerberg C, Fallon PG, Nilsson G, Lunderius-Andersson C. Mast cells as sensors of cell injury through IL-33 recognition. J Immunol. 2011 Feb 15;186(4):2523-8. PubMed PMID: 21239713. Epub 2011/01/18. eng.
15. Lindgren BR, Grundstrom N, Andersson RG. Comparison of the effects of clonidine and guanfacine on the histamine liberation from human mast cells and basophils and on the human bronchial smooth muscle activity. Arzneimittelforschung. 1987 May;37(5):551-3. PubMed PMID: 2441713. Epub 1987/05/01. eng.
16. Anderson CD, Lindgren BR, Andersson RG. Effects of clonidine on the dermal inflammatory cell response of experimental toxic and allergic contact reactions and intradermal hypersensitivity. Int Arch Allergy Appl Immunol. 1987;83(4):371-6. PubMed PMID: 3610350. Epub 1987/01/01. eng.
17. Lavand'homme PM, Eisenach JC. Perioperative administration of the alpha2-adrenoceptor agonist clonidine at the site of nerve injury reduces the development of mechanical hypersensitivity and modulates local cytokine expression. Pain. 2003 Sep;105(1-2):247-54. PubMed PMID: 14499442.
18. Lavand'homme PM, Ma W, De Kock M, Eisenach JC. Perineural alpha(2A)-adrenoceptor activation inhibits spinal cord neuroplasticity and tactile allodynia after nerve injury. Anesthesiology. 2002 Oct;97(4):972-80. PubMed PMID: 12357167.
19. Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs. 2000 Feb;59(2):263-8; discussion 9-70. PubMed PMID: 10730549. Epub 2000/03/24. eng.
20. Brummett CM, Norat MA, Palmisano JM, Lydic R. Perineural administration of dexmedetomidine in combination with bupivacaine enhances sensory and motor blockade in sciatic nerve block without inducing neurotoxicity in rat. Anesthesiology. 2008 Sep;109(3):502-11. PubMed PMID: 18719449. Pubmed Central PMCID: 2709835. Epub 2008/08/23. eng.
21. Cosar M, Eser O, Fidan H, Sahin O, Buyukbas S, Ela Y, et al. The neuroprotective effect of dexmedetomidine in the hippocampus of rabbits after subarachnoid hemorrhage. Surg Neurol. 2009 Jan;71(1):54-9; discussion 9. PubMed PMID: 18207556. Epub 2008/01/22. eng.
22. Whitlock EL, Brenner MJ, Fox IK, Moradzadeh A, Hunter DA, Mackinnon SE. Ropivacaine-induced peripheral nerve injection injury in the rodent model. Anesth Analg. 2010 Jul;111(1):214-20. PubMed PMID: 20442258. Epub 2010/05/06. eng.
23. Eckerson HW, Wyte CM, La Du BN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet. 1983 Nov;35(6):1126-38. PubMed PMID: 6316781. Pubmed Central PMCID: 1685985. Epub 1983/11/01. eng.
24. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 2004 Feb;37(2):112-9. PubMed PMID: 14725941. Epub 2004/01/17. eng.
25. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005 Dec;38(12):1103-11. PubMed PMID: 16214125. Epub 2005/10/11. eng.
26. Rotshenker S. Wallerian degeneration: the innate-immune response to traumatic nerve injury. J Neuroinflammation. 2011;8:109. PubMed PMID: 21878125. Pubmed Central PMCID: 3179447. Epub 2011/09/01. eng.
27. El-Benna J, Dang PM, Gougerot-Pocidalo MA, Elbim C. Phagocyte NADPH oxidase: a multicomponent enzyme essential for host defenses. Arch Immunol Ther Exp (Warsz). 2005 May-Jun;53(3):199-206. PubMed PMID: 15995580. Epub 2005/07/05. eng.
28. Brehm M, Schiller E, Zeller WJ. Quantification of reactive oxygen species generated by alveolar macrophages using lucigenin-enhanced chemiluminescence-methodical aspects. Toxicol Lett. 1996 Oct;87(2-3):131-8. PubMed PMID: 8914621. Epub 1996/10/01. eng.
29. Park JB. Phagocytosis induces superoxide formation and apoptosis in macrophages. Exp Mol Med. 2003 Oct 31;35(5):325-35. PubMed PMID: 14646585. Epub 2003/12/04. eng.
30. Souza Freitas V, de Andrade Santos PP, de Almeida Freitas R, Pereira Pinto L, de Souza LB. Mast cells and matrix metalloproteinase 9 expression in actinic cheilitis and lip squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Sep;112(3):342-8. PubMed PMID: 21612954. Epub 2011/05/27. eng.
31. Hanata K, Yamaguchi N, Yoshikawa K, Mezaki Y, Miura M, Suzuki S, et al. Soluble EMMPRIN (extra-cellular matrix metalloproteinase inducer) stimulates the migration of HEp-2 human laryngeal carcinoma cells, accompanied by increased MMP-2 production in fibroblasts. Arch Histol Cytol. 2007 Dec;70(5):267-77. PubMed PMID: 18431027. Epub 2008/04/24. eng.
32. Wilkinson JM, Davidson RK, Swingler TE, Jones ER, Corps AN, Johnston P, et al. MMP-14 and MMP-2 are key metalloproteases in Dupuytren's disease fibroblast-mediated contraction. Biochim Biophys Acta. 2012 Jun;1822(6):897-905. PubMed PMID: 22342364. Epub 2012/02/22. eng.
33. Orsini G, Mazzoni A, Orciani M, Putignano A, Procaccini M, Falconi M, et al. Matrix metalloproteinase-2 expression induced by two different adhesive systems on human pulp fibroblasts. J Endod. 2011 Dec;37(12):1663-7. PubMed PMID: 22099901. Epub 2011/11/22. eng.
34. Noli C, Miolo A. The role of mast cells in the early stages of wound healing. Int Wound J. 2010 Dec;7(6):540. PubMed PMID: 21073684. Epub 2010/11/16. eng.
35. He S, Gaca MD, Walls AF. The activation of synovial mast cells: modulation of histamine release by tryptase and chymase and their inhibitors. Eur J Pharmacol. 2001 Feb 2;412(3):223-9. PubMed PMID: 11166285. Epub 2001/02/13. eng.
36. He SH, Xie H, Zhang XJ, Wang XJ. Inhibition of histamine release from human mast cells by natural chymase inhibitors. Acta Pharmacol Sin. 2004 Jun;25(6):822-6. PubMed PMID: 15169639. Epub 2004/06/01. eng.
37. Harvima IT, Nilsson G. Mast cells as regulators of skin inflammation and immunity. Acta Derm Venereol. 2011 Oct;91(6):644-50. PubMed PMID: 21879235. Epub 2011/09/01. eng.
38. Iddamalgoda A, Le QT, Ito K, Tanaka K, Kojima H, Kido H. Mast cell tryptase and photoaging: possible involvement in the degradation of extra cellular matrix and basement membrane proteins. Arch Dermatol Res. 2008 Apr;300 Suppl 1:S69-76. PubMed PMID: 17968569. Epub 2007/10/31. eng.
39. Tani K, Ogushi F, Kido H, Kawano T, Kunori Y, Kamimura T, et al. Chymase is a potent chemoattractant for human monocytes and neutrophils. J Leukoc Biol. 2000 Apr;67(4):585-9. PubMed PMID: 10770293. Epub 2000/04/19. eng.
40. Terakawa M, Tomimori Y, Goto M, Fukuda Y. Mast cell chymase induces expression of chemokines for neutrophils in eosinophilic EoL-1 cells and mouse peritonitis eosinophils. Eur J Pharmacol. 2006 May 24;538(1-3):175-81. PubMed PMID: 16690053. Epub 2006/05/13. eng.
41. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265-75. PubMed PMID: 14907713.